Cochrane Review: What We Know and Don’t Yet Know—About Nicotine Pouches and Smoking Cessation

A new Cochrane systematic review has examined whether oral nicotine pouches can help people stop smoking, vaping, or using other forms of tobacco. While early evidence is promising in showing lower toxicant exposure, the review concludes that more data is needed to determine their long-term impact on cessation outcomes. What the Review Found The Cochrane…

Portugal Introduces Nicotine Pouch Tax: A Step Toward Regulation and Responsible Harm Reduction

Portugal has taken a decisive step toward formalising the regulation of nicotine pouches by creating a new excise tax category for these tobacco-free, smokeless products. Beginning in 2026, nicotine pouches will be subject to a tax rate of €0.065 per gram of net weight, effectively bringing them under the country’s broader tobacco and nicotine tax…

The Next Evolution of Alternative Nicotine: What Science and Innovation Reveal

The nicotine market is evolving faster than ever. Fueled by shifting consumer preferences, regulatory changes, and ongoing scientific advances, a new generation of smoke-free products is taking hold shape. As traditional tobacco declines, modern oral and inhalable formats are emerging as the next frontier for harm reduction, offering adult smokers safer, more convenient, and increasingly…

Rutgers Study Finds Nicotine Pouches Pose Minimal Uptake Risk Among Non-Users

A landmark study from Rutgers University offers the clearest national picture yet of nicotine pouch use in the United States, and the findings reinforce what harm reduction advocates have long argued: nicotine pouches are primarily being used by adults with prior tobacco experience, not by nicotine-naïve individuals. A New National Estimate The Rutgers-led research, published…